InvestorsHub Logo
Followers 99
Posts 5356
Boards Moderated 0
Alias Born 08/27/2011

Re: biopharm post# 223708

Tuesday, 06/16/2015 7:02:02 AM

Tuesday, June 16, 2015 7:02:02 AM

Post# of 346050
It makes perfect sense that approval "trial halt" could come at anytime. Peregrine is planning TWO late phase trials in the coming months which could lead to approval based on ORR. Get first approval for 2nd line lung now and expand indications based on ORR breast and frontline lung.


I do not want Peregrine to go it alone but possibly they are moving ahead in the approval process faster then they thought.....

Get an FDA approval 2015? then partner...

That will be for big dollars...

Genius.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News